MARKET ACCESS LANDSCAPE FOR BIOSIMILARS IN SWEDEN: AN UNTAPPED POTENTIAL?

被引：0
|
作者：
Olsson, K. [1 ]
Carlqvist, P. [1 ]
机构：
[1] Nord Market Access AB, Stockholm, Sweden
来源：
VALUE IN HEALTH | 2019年 / 22卷
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PBI74
引用
收藏
页码：S430 / S431
页数：2
相关论文
共 50 条
  • [1] Current Market and Regulatory Landscape of Biosimilars
    Bhatt, Valkal
    AMERICAN JOURNAL OF MANAGED CARE, 2018, 24 (21): : S451 - S456
  • [2] Biosimilars and market access: a question of comparability and costs?
    Simoens, Steven
    Verbeken, Gilbert
    Huys, Isabelle
    TARGETED ONCOLOGY, 2012, 7 (04) : 227 - 231
  • [3] Market access of biosimilars: not only a cost issue
    Simoens, S.
    Verbeken, G.
    Huys, I.
    ONCOLOGIE, 2011, 13 (05) : 218 - 221
  • [4] A health economic guide to market access of biosimilars
    Simoens, Steven
    Vulto, Arnold G.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2021, 21 (01) : 9 - 17
  • [5] Biosimilars and market access: a question of comparability and costs?
    Steven Simoens
    Gilbert Verbeken
    Isabelle Huys
    Targeted Oncology, 2012, 7 : 227 - 231
  • [6] BIOSIMILARS: MARKET ACCESS AND MARKET PENETRATION - A COMPARISON OF FRANCE AND GERMANY
    Freiberg, M.
    Schwarz, R.
    Khoury, C.
    VALUE IN HEALTH, 2016, 19 (07) : A442 - A442
  • [7] ROLE OF BUDGET IMPACT ANALYSIS IN MARKET ACCESS OF BIOSIMILARS
    Singh, A.
    Jha, R. K.
    Mazumder, D.
    Kapoor, A.
    VALUE IN HEALTH, 2015, 18 (07) : A529 - A529
  • [8] Huge potential offered by untapped cruise market
    不详
    NAVAL ARCHITECT, 2004, : 68 - 68
  • [9] BIOSIMILARS: BARRIERS AND OPPORTUNITIES TO MARKET ACCESS IN THE UNITED STATES
    Chopra, I
    Arkells, N.
    Chopra, A. S.
    VALUE IN HEALTH, 2018, 21 : S93 - S93
  • [10] Cost and access changes with TNFa inhibitor biosimilars entering the market
    Visingardi, J. V.
    Sherwood, B.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2024, 144 (08) : S178 - S178
12345